JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 1 27-31
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuchida, T.
Right arrow Articles by Konishi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuchida, T.
Right arrow Articles by Konishi, J.

SPECT Images of Technetium-99m-Ethyl Cysteinate Dimer in Cerebrovascular Diseases: Comparison with Other Cerebral Perfusion Tracers and PET

Tatsuro Tsuchida, Sadahiko Nishizawa, Yoshiharu Yonekura, Norihiro Sadato, Yasushi Iwasaki, Toru Fujita, Naoki Matoba, Yasuhiro Magata, Nagara Tamaki and Junji Konishi

Departments of Nuclear Medicine and Brain Pathophysiology, Kyoto University Faculty of Medicine, Kyoto, Japan

Correspondence: For correspondence or reprints contact: Sadahiko Nishizawa, MD, Department of Nuclear Medicine, Kyoto University Faculty of Medicine, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-01, Japan.

ABSTRACT

To assess the clinical role of 99mTc-ethyl cysteinate dimer (ECD) as a cerebral perfusion tracer, 10 patients with unilateral cerebral infarction were studied. Methods: ECD SPECT images were compared with IMP and/or HMPAO SPECT in nine patients, seven in chronic phases and two in subacute phases. Five of these patients and one additional patient with chronic infarction received PET imaging in order to compare ECD distribution with quantitative regional cerebral blood flow (rCBF) and oxygen metabolism (rCMRO2) images. Results: In patients with chronic cerebral infarction, regression analysis showed excellent correlation between ECD and IMP in the uptake ratio of lesions-to-nonaffected cortices (r = 0.91). In two cases of subacute infarction, decreased uptake of ECD was observed in the area of "luxury perfusion," which showed elevated or preserved rCBF with diminished rCMRO2. On visual analysis, ECD image contrast was less prominent compared to that of IMP, but contrast was better than that of HMPAO. Conclusions: ECD uptake showed a curvilinear relationship against rCBF, suggesting flow-limited uptake in a high flow range. ECD is a clinically useful cerebral perfusion tracer with distinct characteristics when compared with other available agents.

Key Words: technetium-99m-ethyl cysteinate dimer • cerebrovascular disease




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
T. J O'Brien, B. H Brinkmann, B. P Mullan, E. L So, M. F Hauser, M. K O'Connor, J. Hung, and C. R Jack
Comparative study of 99mTc-ECD and 99mTc-HMPAO for peri-ictal SPECT: qualitative and quantitative analysis
J. Neurol. Neurosurg. Psychiatry, March 1, 1999; 66(3): 331 - 339.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.